Donald Moylan

Specimen Provenance Testing Identifies Contamination That Affects Molecular Prognostic Assay Results in Prostate Cancer Biopsy Specimens.

K. Wojno, L. Wojno, Caitlyn Minutella, 2018, Urology.

Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer.

David C. Miller, R. Dunn, J. Montie, 2013, The Journal of urology.

Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer.

David C. Miller, R. Dunn, J. Montie, 2012, The Journal of urology.

Prostatectomy‐based validation of combined urine and plasma test for predicting high grade prostate cancer

B. Shahbaba, Wanlong Ma, M. Albitar, 2018, The Prostate.

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy

B. Shahbaba, Wanlong Ma, M. Albitar, 2017, Journal of Cancer.